LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, today announced its ArrowADVANTAGE 5 pressure-injectable ...
Patients: A total of 113 pediatric patients (77 men), median age 10.3 months, admitted between July 10, 2014, and February 5, 2015, were divided into two groups: the novel-catheter group and the ...
Monitoring of LAP and CVP (an estimate of right atrial pressure) is invasive procedures, so it is unethical to insert a novel catheter and a traditional catheter into the same patient. However, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback